
TEGAFUR 20 mg + GIMERACIL 5.8 mg + OTERACIL 15.8 mg (Tegonat) is a prescription oral chemotherapy medicine used to treat gastric cancer and certain other solid tumours as recommended by an oncologist. This combination is designed to enhance the anticancer activity of tegafur while helping reduce gastrointestinal side effects. It may be used alone or with other chemotherapy medicines as part of a comprehensive cancer treatment plan.
| Generic name | TEGAFUR/GIMERACIL |
| Strength | 20 mg + 5.8 mg |
| Manufacturer | Natco |
| Package size | 42 Capsules |
| Used for | Advanced stomach (gastric) cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Tegafur is converted into 5-fluorouracil (5-FU) in the body. This active medicine interferes with the production of DNA and RNA in rapidly dividing cancer cells, helping stop their growth and causing cell death. Gimeracil slows the breakdown of 5-FU, allowing it to remain active for longer. Oteracil reduces the activity of 5-FU in the gastrointestinal tract, helping limit digestive side effects.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.